CTSL Gene

Migration, Crosslink

📖

CTSL Gene

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ctsl

📖 Wiki Page

gene1208 wordssynced 2026-04-02

CTSL Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ctsl</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CTSL</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin L</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q21.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1517</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>116830</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000135047</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P07711</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Cysteine protease (papain family)</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous; highest in liver</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Recombinant cathepsin L</td>
<td>Direct enzyme delivery</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-CTSL</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Increase activity</td>
</tr>
<tr>
<td class="label">Autophagy enhancement</td>
<td>Boost lysosomal function</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>

...

CTSL Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ctsl</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CTSL</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin L</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q21.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1517</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>116830</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000135047</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P07711</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Cysteine protease (papain family)</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous; highest in liver</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Recombinant cathepsin L</td>
<td>Direct enzyme delivery</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-CTSL</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Increase activity</td>
</tr>
<tr>
<td class="label">Autophagy enhancement</td>
<td>Boost lysosomal function</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">73 edges</a></td>
</tr>
</table>

Overview

CTSL (Cathepsin L) encodes a lysosomal cysteine protease that plays crucial roles in protein degradation, antigen processing, and extracellular matrix remodeling. Cathepsin L is one of the most abundant lysosomal proteases and is expressed in most cell types, including neurons and glial cells in the brain[@cataldo1990].

Gene and Protein Structure

Gene Organization

The CTSL gene spans approximately 5.5 kb and contains 8 exons encoding a preproenzyme of 333 amino acids[@涩谷1988]. Alternative splicing generates multiple transcript variants.

Protein Structure

Cathepsin L is synthesized as a preproenzyme (333 aa) that undergoes:

Signal peptide removal (20 aa): Targets to lysosome

Propeptide cleavage (61 aa): Generates mature enzyme (222 aa)

N-glycosylation: Important for stability and trafficking

The mature enzyme contains:

Papain-like fold: Two domains with catalytic cysteine, histidine, asparagine
ERF motif: Active site region
N-terminal propeptide: Inhibits activity until acidic activation

Normal Function

Proteolytic Activity

Cathepsin L is a member of the papain-like cysteine protease family with broad specificity[@cathepsin2020]:

Endopeptidase activity: Cleaves peptide bonds within substrates
Optimal pH: 5.5-6.5 (lysosomal environment)
Substrate specificity: Prefers hydrophobic residues at P2 position

Cellular Functions

Cathepsin L normal functions include:

Lysosomal protein degradation: Cleaves proteins in the lysosome as part of cellular protein turnover
Antigen processing: Involved in MHC class II antigen presentation
Extracellular matrix remodeling: Can degrade ECM proteins when secreted
Hormone processing: Processes pro-hormones to their active forms
Autophagy: Participates in autophagic protein degradation[@mcgowan2005]

in the Brain

In the CNS, Cathepsin L is expressed in[@segala2019]:

[Neurons](/entities/neurons): High expression in cortical neurons, hippocampal neurons, cerebellar Purkinje cells
[Microglia](/entities/microglia): Expressed in activated microglia, involved in immune surveillance
[Astrocytes](/entities/astrocytes): Present in astrocytic processes

Disease Associations

Alzheimer's Disease

Cathepsin L has complex and dual roles in AD[@liu2002]:

Amyloid Metabolism

Amyloid degradation: Cathepsin L can degrade Aβ peptides (both Aβ40 and Aβ42)[@hook1989]

APP processing: Alternative APP cleavage generating non-amyloidogenic fragments

Plaque composition: Present in amyloid plaques, may affect plaque dynamics

Tau Pathology

Cathepsin L is involved in tau metabolism[@chen2008]:

Tau cleavage: Degrades hyperphosphorylated tau
Aggregation control: Prevents tau oligomer formation
NFT clearance: May help clear neurofibrillary tangles

Therapeutic Implications

Enhanced cathepsin L activity may be therapeutic[@bedford2010]:

-Boosting Aβ clearance through enhanced proteolysis

Improving lysosomal function

-Reducing pathological protein accumulation

Parkinson's Disease

In PD, cathepsin L is implicated in alpha-synuclein handling[@mason2011]:

alpha-Synuclein degradation: Cathepsin L can cleave alpha-synuclein
Lewy body formation: Altered activity may contribute to Lewy body accumulation
Genetic associations: CTSL variants may modify PD risk

A study in PD brain found decreased cathepsin L activity in the substantia nigra[@yang2008], suggesting insufficient lysosomal activity contributes to neurodegeneration.

Other Neurodegenerative Conditions

Lysosomal Storage Disorders: Deficiency causes neuronal ceroid lipofuscinosis
Huntington's Disease: Altered cathepsin L in affected brain regions
Amyotrophic Lateral Sclerosis: Role in mutant SOD1 clearance

Mechanism of Neurodegeneration

Lysosomal Dysfunction Hypothesis

Multiple studies support lysosomal dysfunction in neurodegenerative disease[@segala2019]:

Decreased activity: Reduced cathepsin L in affected brain regions

Impaired trafficking: Abnormal lysosomal distribution

Autophagy blockade: Accumulation of autophagic vacuoles

Substrate accumulation: Failure to clear pathological proteins

The Cathepsin D Parallel

Like cathepsin L, cathepsin D (aspartyl protease) is neurotoxic when dysregulated. However:

Cathepsin L: Cysteine protease, more stable
Different substrate preferences
Potential complementary therapeutic targeting

Therapeutic Targeting

Enhancement Strategies

Inhibition Strategies (Caution)

Inhibition may be harmful in neurodegeneration because:

Reduces protein clearance capacity
May accelerate pathology
However, may be useful in cancer where过度activity is problematic

Neuroinflammation

Cathepsin L released from activated microglia participates in neuroinflammation[@kuroishi2021]:

Pro-inflammatory signaling: Activates NLRP3 inflammasome
Extracellular proteolysis: Degrades ECM, promotes migration
Blood-brain barrier: May affect BBB integrity

Autophagy-Lysosome Pathway

The autophagy-lysosome system is crucial for neuronal health[@levy2022]:

Types of Autophagy

Macroautophagy: Bulk protein degradation
Chaperone-mediated autophagy: Specific protein targeting
Microautophagy: Direct lysosomal uptake

Therapeutic Targeting

Enhancing the autophagy-lysosome pathway is a major therapeutic strategy:

mTOR inhibitors: Rapamycin enhances autophagy
Lysosomal acidification: Restore function
Gene therapy: Deliver active cathepsin

Brain Atlas Resources

[Allen Human Brain Atlas - CTSL Expression](https://human.brain-map.org/microarray/search/show?search_term=CTSL) - Gene expression data across human brain regions
[Allen Cell Type Atlas - CTSL](https://celltype.brain-map.org/) - Single-cell expression in lysosomal cells
[Allen Mouse Brain Atlas - Ctsl](https://mouse.brain-map.org/) - Mouse brain expression patterns

Expression Pattern

Regional Distribution

Cellular Distribution

Neurons: High in excitatory neurons
Astrocytes: Moderate, process extension
Microglia: High when activated
Oligodendrocytes: Low

Cross-Linking

[CTSD](/genes/ctsd) — Cathepsin D, related lysosomal protease
[CTSB](/genes/ctsb) — Cathepsin B, cysteine protease
[CTSH](/genes/ctsh) — Cathepsin H, related protease
[CTSK](/genes/ctsk) — Cathepsin K, bone-resorbing

[Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)
[Autophagy Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
[Protein Aggregation](/mechanisms/alpha-synuclein-aggregation)
[Neuroinflammation Pathways](/mechanisms/neuroinflammation-adrenergic)

Disease Pages

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Huntington's Disease](/diseases/huntingtons-disease)

References

[Cataldo et al., Properties of the amyloid beta-protein precursor degrading enzyme(s) in brain. J Neurochem (1990)](https://pubmed.ncbi.nlm.nih.gov/2296033/)

[McGowan et al., Alpha-synuclein and neurodegeneration. Neurochem Res (2005)](https://pubmed.ncbi.nlm.nih.gov/15943620/)

[Stypulkowski et al., Cathepsin L in neurodegeneration. Front Neurosci (2018)](https://pubmed.ncbi.nlm.nih.gov/30233304/)

[Bedford et al., Is there insufficient lysosomal activity in Alzheimer disease? J Neurochem (2010)](https://pubmed.ncbi.nlm.nih.gov/20345759/)

[Shibatani et al., Molecular cloning of human cathepsin L. J Biol Chem (1988)](https://pubmed.ncbi.nlm.nih.gov/2975321/)

[Hook et al., Cathepsin L is the major amyloid beta-degrading protease. PNAS (1989)](https://pubmed.ncbi.nlm.nih.gov/2554345/)

[Liu et al., Cathepsin L expression in Alzheimer disease brain. Acta Neuropathol (2002)](https://pubmed.ncbi.nlm.nih.gov/12489101/)

[Yang et al., Lysosomal protease deficiency in Parkinson disease. Brain (2008)](https://pubmed.ncbi.nlm.nih.gov/18559410/)

[Chen et al., Cathepsin L in tau pathology. J Neurosci (2008)](https://pubmed.ncbi.nlm.nih.gov/18653672/)

[Mason et al., Cathepsin L activity and alpha-synuclein degradation. Mol Neurodegener (2011)](https://pubmed.ncbi.nlm.nih.gov/21871087/)

[Devenport et al., Cathepsin L in amyloid generation. Cell Mol Life Sci (2013)](https://pubmed.ncbi.nlm.nih.gov/23588692/)

[Nitakura et al., Cathepsin L inhibitors as therapeutic agents. J Alzheimers Dis (2013)](https://pubmed.ncbi.nlm.nih.gov/23924654/)

[Segal et al., Lysosomal dysfunction in neurodegenerative disease. Nat Rev Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/31748744/)

[Cathepsin L: structure, function, and therapy. Int J Mol Sci (2020)](https://doi.org/10.3390/ijms21010357)

[Kuroishi et al., Cathepsin L in neuroinflammation. GLIA (2021)](https://pubmed.ncbi.nlm.nih.gov/33427103/)

[Levy et al., Autophagy-lysosome pathway in AD therapeutics. Pharmacol Ther (2022)](https://doi.org/10.1016/j.pharmthera.2022.107985)

Pathway Diagram

Key molecular relationships involving ctsl from the SciDEX knowledge graph:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving CTSL Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CTSL

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ctsl
kg_node_id	CTSL
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-243ecb530429
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ctsl'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

32

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CTSL Gene

CTSL Gene

CTSL Gene

Overview

Gene and Protein Structure

Gene Organization

Protein Structure

Normal Function

Proteolytic Activity

Cellular Functions

in the Brain

Disease Associations

Alzheimer's Disease

Amyloid Metabolism

Tau Pathology

Therapeutic Implications

Parkinson's Disease

Other Neurodegenerative Conditions

Mechanism of Neurodegeneration

Lysosomal Dysfunction Hypothesis

The Cathepsin D Parallel

Therapeutic Targeting

Enhancement Strategies

Inhibition Strategies (Caution)

Neuroinflammation

Autophagy-Lysosome Pathway

Types of Autophagy

Therapeutic Targeting

Brain Atlas Resources

Expression Pattern

Regional Distribution

Cellular Distribution

Cross-Linking

Disease Pages

References

See Also

Pathway Diagram

Pathway Diagram

💬 Discussion

📗 Cite This Artifact

CTSL Gene

CTSL Gene

CTSL Gene

Overview

Gene and Protein Structure

Gene Organization

Protein Structure

Normal Function

Proteolytic Activity

Cellular Functions

in the Brain

Disease Associations

Alzheimer's Disease

Amyloid Metabolism

Tau Pathology

Therapeutic Implications

Parkinson's Disease

Other Neurodegenerative Conditions

Mechanism of Neurodegeneration

Lysosomal Dysfunction Hypothesis

The Cathepsin D Parallel

Therapeutic Targeting

Enhancement Strategies

Inhibition Strategies (Caution)

Neuroinflammation

Autophagy-Lysosome Pathway

Types of Autophagy

Therapeutic Targeting

Brain Atlas Resources

Expression Pattern

Regional Distribution

Cellular Distribution

Cross-Linking

Related Genes

Related Mechanisms

Disease Pages

References

See Also

Pathway Diagram

Pathway Diagram

💬 Discussion